These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2784212)

  • 41. Natural cytotoxic cell-specific cytotoxic factor produced by IL-3-dependent basophilic/mast cells. Relationship to TNF.
    Richards AL; Okuno T; Takagaki Y; Djeu JY
    J Immunol; 1988 Nov; 141(9):3061-6. PubMed ID: 3262677
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The adenovirus E3-14.7K protein is a general inhibitor of tumor necrosis factor-mediated cytolysis.
    Gooding LR; Sofola IO; Tollefson AE; Duerksen-Hughes P; Wold WS
    J Immunol; 1990 Nov; 145(9):3080-6. PubMed ID: 2145367
    [TBL] [Abstract][Full Text] [Related]  

  • 43. WEHI-164 clone 2F: in vitro antitumor effects of tumor necrosis factor and gamma-interferon.
    Lattime EC; Stutman O
    Nat Immun; 1992; 11(1):34-45. PubMed ID: 1611280
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
    Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
    J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Laminin inhibits the recognition of tumor target cells by murine natural killer (NK) and natural cytotoxic (NC) lymphocytes.
    Hiserodt JC; Laybourn KA; Varani J
    Am J Pathol; 1985 Oct; 121(1):148-55. PubMed ID: 2931993
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sensitivity of human renal cell carcinoma lines to TNF, adriamycin, and combination: role of TNF mRNA induction in overcoming resistance.
    Safrit JT; Belldegrun A; Bonavida B
    J Urol; 1993 May; 149(5):1202-8. PubMed ID: 8483246
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tumorigenicity and lysis by natural killers.
    Collins JL; Patek PQ; Cohn M
    J Exp Med; 1981 Jan; 153(1):89-106. PubMed ID: 6161207
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of tumor necrosis factor-mediated lysis by spleen cell-conditioned medium.
    Sasaki CY; Patek PQ
    Int J Immunopharmacol; 1994 Apr; 16(4):301-9. PubMed ID: 8045670
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Promotion of mouse fibroblast proliferation by IgE-dependent activation of mouse mast cells: role for mast cell tumor necrosis factor-alpha and transforming growth factor-beta 1.
    Kendall JC; Li XH; Galli SJ; Gordon JR
    J Allergy Clin Immunol; 1997 Jan; 99(1 Pt 1):113-23. PubMed ID: 9003219
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin.
    Seki N; Brooks AD; Carter CR; Back TC; Parsoneault EM; Smyth MJ; Wiltrout RH; Sayers TJ
    J Immunol; 2002 Apr; 168(7):3484-92. PubMed ID: 11907109
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Common expression of a tumor necrosis factor resistance mechanism among gynecological malignancies.
    Powell CB; Mutch DG; Massad LS; Kao MS; Collins JL
    Cancer Immunol Immunother; 1990; 32(2):131-6. PubMed ID: 2289205
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differences in the bioactivity of recombinant human TNF, LT, and T-cell-derived LT-3 on transformed cells in vitro and the Meth A tumor growing in BALB/c mice.
    Granger GA; Masunaka I; Averbook B; Kobayashi M; Fitzgerald M; Yamamoto R
    J Biol Response Mod; 1988 Oct; 7(5):488-97. PubMed ID: 3263472
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of tumor necrosis factor in macrophage activation and tumoricidal activity.
    Mace KF; Ehrke MJ; Hori K; Maccubbin DL; Mihich E
    Cancer Res; 1988 Oct; 48(19):5427-32. PubMed ID: 3416299
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The E1B 19,000-molecular-weight protein of group C adenoviruses prevents tumor necrosis factor cytolysis of human cells but not of mouse cells.
    Gooding LR; Aquino L; Duerksen-Hughes PJ; Day D; Horton TM; Yei SP; Wold WS
    J Virol; 1991 Jun; 65(6):3083-94. PubMed ID: 1827845
    [TBL] [Abstract][Full Text] [Related]  

  • 55. TNF induction of EL4 hyposensitivity to lysis by recombinant (soluble) and membrane-associated TNFs: TNF binding, internalization, and degradation.
    Fishman M; Costlow M
    Cell Immunol; 1994 Apr; 154(1):453-67. PubMed ID: 8131213
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induction of TNF-sensitive cellular phenotype by c-Myc involves p53 and impaired NF-kappaB activation.
    Klefstrom J; Arighi E; Littlewood T; Jäättelä M; Saksela E; Evan GI; Alitalo K
    EMBO J; 1997 Dec; 16(24):7382-92. PubMed ID: 9405367
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Perforin-independent CD8(+) T-cell-mediated cytotoxicity of alveolar epithelial cells is preferentially mediated by tumor necrosis factor-alpha: relative insensitivity to Fas ligand.
    Liu AN; Mohammed AZ; Rice WR; Fiedeldey DT; Liebermann JS; Whitsett JA; Braciale TJ; Enelow RI
    Am J Respir Cell Mol Biol; 1999 May; 20(5):849-58. PubMed ID: 10226053
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Natural cytotoxic (NC) cell activity in basophilic cells: release of NC-specific cytotoxic factor by IgE receptor triggering.
    Okuno T; Takagaki Y; Pluznik DH; Djeu JY
    J Immunol; 1986 Jun; 136(12):4652-8. PubMed ID: 2940298
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phospholipase A2 activation in cultured mouse hepatocytes exposed to tumor necrosis factor-alpha.
    Adamson GM; Carlson TJ; Billings RE
    J Biochem Toxicol; 1994 Aug; 9(4):181-90. PubMed ID: 7853352
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dominance of resistance to the cytocidal effect of tumor necrosis factor in heterokaryons formed by fusion of resistant and sensitive cells.
    Nophar Y; Holtmann H; Ber R; Wallach D
    J Immunol; 1988 May; 140(10):3456-60. PubMed ID: 2834438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.